AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23,316,384 | +79.5% | 1,856,400 | +58.5% | 0.42% | +65.5% |
| Q1 2023 | $12,986,390 | +106.1% | 1,171,000 | +126.9% | 0.26% | +110.7% |
| Q4 2022 | $6,300,360 | -2.6% | 516,000 | -0.4% | 0.12% | +21.0% |
| Q2 2019 | $6,468,000 | -8.2% | 518,309 | 0.0% | 0.10% | -8.3% |
| Q1 2019 | $7,049,000 | +127.8% | 518,309 | +60.5% | 0.11% | +91.2% |
| Q4 2018 | $3,094,000 | -85.5% | 323,009 | -81.7% | 0.06% | -77.8% |
| Q3 2018 | $21,318,000 | -80.7% | 1,763,277 | -75.1% | 0.26% | -80.5% |
| Q2 2018 | $110,472,000 | +3.9% | 7,072,500 | 0.0% | 1.32% | -0.1% |
| Q1 2018 | $106,370,000 | +32.7% | 7,072,500 | +26.9% | 1.32% | +30.1% |
| Q4 2017 | $80,188,000 | – | 5,572,500 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |